Precision Medicine in Head and Neck Cancer
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: closed (20 May 2024) | Viewed by 274
Special Issue Editor
Special Issue Information
Dear Colleagues,
We cordially invite you to submit your original research and review articles for an upcoming Special Issue of the Journal of Personalized Medicine, focused on "Precision Medicine in Head and Neck Cancer". This Special Issue aims to report on the latest advancements and breakthroughs in the field, highlighting innovative diagnostic and therapeutic approaches.
Monoclonal antibodies for treating head and neck cancer, as well as applications of artificial intelligence and large language models to assist in cancer diagnosis, treatment, and patient care, are the most widely known developments towards personalized medicine in head and neck oncology. However, these are just a few examples, and we welcome a diverse range of topics related to personalized medicine in head and neck cancer.
We look forward to receiving your valuable contributions to this Special Issue and to advancing our collective understanding of personalized medicine in head and neck cancer.
Best regards,
Dr. Alberto Maria Saibene
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- personalized medicine
- head and neck cancer
- monoclonal antibodies
- cancer diagnosis
- cancer treatment
- artificial intelligence
- large language models
- cancer patient care
- biomarkers
- targeted therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
